Application Fees is a feature that allows platform owners to charge a fee on top of payment transactions made by their connected accounts. This helps them earn revenue on top of the usage of the Stripe platform.
With Databox you can track all your metrics from various data sources in one place.
Used to show a simple Metric or to draw attention to one key number.
Databox is a business analytics software that allows you to track and visualize your most important metrics from any data source in one centralized platform.
To track Application Fees using Databox, follow these steps:
Discounts (excl. Canceled Subscriptions) is a metric that reflects the total revenue reduction due to discounts applied to monthly recurring revenue (MRR) of a business through Stripe.
The New Subscriptions (incl. Trials) metric tracks the number of new recurring payments or subscription sign-ups including Trials made by customers in a given period of time.
New Subscriptions by Plan Name metric measures the number of new subscriptions created for each plan in a given time frame, providing insights into the performance and popularity of different subscription plans.
Churned Customers measures the rate at which customers stop using a company's product or service within a certain period of time. It is an important metric for subscription-based businesses to track customer retention and identify areas for improvement.
Churned Customers (Delinquent) metric measures the number of customers who fail to pay recurring payments and cancel their subscription. This helps to track the loss of revenue due to customer attrition.
Overdue Invoices Amount metric in Stripe tracks the total amount of unpaid invoices that are past their due date, providing an overview of the outstanding balance that customers owe.
ARR by Plan Name is a metric that calculates the total Annual Recurring Revenue generated by each subscription plan in a given period, providing insights into which plans are driving the most revenue for a business.
Net Active Trials measures the change in the Active Trials over a specific time period.